Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine

In previous studies, it has been shown that the granulocyte macrophage‐colony stimulating factor (GM‐CSF) or interleukin‐2 (IL‐2) surface modified MB49 bladder cancer stem cells (MCSCs) vaccine could induce a specific antitumor immunity and against bladder cancer in mice model respectively. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun‐yan, Hua, Rui, Liu, Li, Zhan, Xiaomin, Chen, Simei, Quan, Song, Chu, Qing‐jun, Zhu, Yong‐tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345636/
https://www.ncbi.nlm.nih.gov/pubmed/28205361
http://dx.doi.org/10.1002/cam4.1023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345636/
https://www.ncbi.nlm.nih.gov/pubmed/28205361
http://dx.doi.org/10.1002/cam4.1023

Ejemplares similares